The delisting is a formality — the stock has been suspended and the company is in Chapter 11. No further trading catalyst exists; equity is effectively extinguished. Monitor the bankruptcy docket for any plan of reorganization or asset sale, but recovery for common shareholders is not expected.
Price Chart
Executive Summary
Nasdaq has filed a Form 25-NSE to remove Sangamo Therapeutics' common stock from listing and registration, effective October 16, 2026. The delisting follows a Chapter 11 bankruptcy filing (June 23, 2026), a suspension from trading (May 5, 2026), and a failed appeal to the Nasdaq Hearings Panel. The stock will trade over-the-counter (OTC) with no exchange listing, representing a terminal event for equity holders in a bankrupt company.
Key Facts
- Nasdaq determined Sangamo no longer qualified for listing under Listing Rule 5550(a)(2) (minimum bid price/equity standard).
- The company's common stock was suspended from trading on May 5, 2026.
- Nasdaq's delisting determination became final on August 28, 2026.
- Delisting effective at the opening of trading on October 16, 2026.
- Sangamo filed for Chapter 11 bankruptcy on June 23, 2026 (case 26-10989 in Delaware).
- The company's independent auditor (Ernst & Young) was terminated effective June 25, 2026, and no replacement has been engaged.
- The company filed a late NT 10-Q on August 17, 2026, citing inability to file due to bankruptcy proceedings and lack of an auditor.
Financial Impact
Equity holders are likely to receive zero recovery in Chapter 11; the stock has been worthless since suspension. Delisting formalizes the end of exchange trading.
Risk Factors
- Equity holders likely receive no distribution in Chapter 11 proceedings.
- OTC trading will have minimal liquidity and no price discovery.
- No auditor engaged and no financial reports filed — complete information blackout.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0001354457-26-000959 |
| Document: 0001354457-26-000959-index-headers.html | 0001354457-26-000959 |
| Document: 0001354457-26-000959-index.html | 0001354457-26-000959 |
| Document: 0001354457-26-000959.txt | 0001354457-26-000959 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 8-K | $0.1100 $0.1200 | ▼ −9.09% | ▼ −9.52% | $0.1200 (−9.09%) |
Oct 6, 2026 19d ago | 25-NSE | $0.1400 $0.1400 | · 0.00% | ▼ −0.98% | $0.1200 (+14.29%) |
Aug 28, 2026 8w ago | 8-K | $0.1600 $0.1600 | · 0.00% | ▼ −0.14% | $0.1200 (+25.00%) |
Aug 12, 2026 10w ago | 8-K | $0.1700 $0.1602 | ▼ −5.76% | ▼ −3.80% | $0.1200 (−29.41%) |
Aug 12, 2026 10w ago | 8-K | $0.1700 $0.1602 | ▲ +5.76% | ▲ +3.80% | $0.1200 (+29.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers